ORM-1153, with optimized antibody and linker design, demonstrates improved pharmacology, low-dose in vivo activity, and favorable repeat-dose tolerability Data show activity across primary acute ...

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the presentation of new preclinical data ...

BOSTON & DAEJEON, South Korea, April 17, 2026--(BUSINESS WIRE)--Orum Therapeutics ("Orum" or the "Company") (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates ...

Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026 Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), ...

BOSTON & DAEJEON, South Korea, December 08, 2025--(BUSINESS WIRE)--Orum Therapeutics ("Orum" or the "Company") (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody ...

Every brand wants to make a good impression online, but having a standout website or social media presence isn’t enough. These days, everyone has an opinion on just about everything, and customers are ...

On October 25, 2024, Oregon Reproductive Medicine LLC dba ORM Fertility (“ORM Fertility” or “ORM”) filed a notice of data breach with the U.S. Department of Health and Human Services Office for Civil ...

After months of anticipation, the 2024 Ballon d'Or ceremony is finally here to crown soccer's best players, clubs and managers. Lamine Yamal (Spain, Barcelona) is the 2024 Kopa Trophy winner. Men's ...

Vertex Pharmaceuticals will use Orum Therapeutics’ dual-precision targeted protein degradation (TPD² ®) technology platform to discover targeted conditioning agents for use with gene editing therapies ...

Add Yahoo as a preferred source to see more of our stories on Google. The tickets for LingOrm 1st Meet The Secret of Us will go live on Sunday, June 9, 2024, at 10 a.m. ICT. They will be available to ...